Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Raffick AR Bowen, MLT, PhD, DClChem, FCACB, DABCC, Janet K Dale, RN, MPH, Margaret Brown, BSc, Steven K Drake, PhD, Tarsilla Moura, Kennichi Dowdell, PhD, Alan T Remaley, MD, PhD, Thomas A Fleisher, MD, Glen L Hortin, MD, PhD, Ebba Nexo, MD, Stephen E Straus, MD, V. Koneti Rao, MD, FRCPA

Blood (2008) 112 (11): 4898.

https://doi.org/10.1182/blood.V112.11.4898.4898

Published: 2008

Journal Articles

Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, Ph.D., Lesley Pesnicak, BS, Lilia Bi, Ph.D., Victoria Hoffmann, DVM, V. Koneti Rao, MD, Stephen E. Straus, MD

Blood (2007) 110 (11): 1385.

https://doi.org/10.1182/blood.V110.11.1385.1385

Published: 2007

Journal Articles

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, PhD, Julie Niemela, BS, MT(ASCP), Janet K. Dale, RN, MPH, Jennifer Puck, MD, V. Koneti Rao, MD, Thomas Fleisher, MD, Stephen E. Straus, MD

Blood (2006) 108 (11): 3900.

https://doi.org/10.1182/blood.V108.11.3900.3900

Published: 2006

Journal Articles

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, PhD, Lesley Pesnicak, BS, Victoria Hoffman, DVM, Kenneth Steadman, BS, Mark Ruddel, MS, V. Koneti Rao, MD, Stephen E. Straus, MD

Blood (2006) 108 (11): 2497.

https://doi.org/10.1182/blood.V108.11.2497.2497

Published: 2006

Journal Articles

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Kennichi C. Dowdell, PhD, Faith Dugan, RN, Janet K. Dale, RN, MPH, Lesley Pesnicak, Lilia Bi, PhD, Scott Penzak, Pharm D, Nilo A. Avila, MD, Thomas A. Fleisher, MD, Jennifer M. Puck, MD, Stephen E. Straus, MD

Blood (2005) 106 (11): 2396.

https://doi.org/10.1182/blood.V106.11.2396.2396

Published: 2005

Journal Articles

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Jorge A. Carrasquillo, MD, Janet K. Dale, RN, MPH, Stephen Bacharach, PhD, Millie Whatley, RNMT, Faith Dugan, RN, Jean Tretler, RN, Elaine S. Jaffe, MD, Wyndham Wilson, MD, Nilo Avila, MD, Stephen E. Straus, MD

Blood (2004) 104 (11): 3850.

https://doi.org/10.1182/blood.V104.11.3850.3850

Published: 2004

NARROW

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

Email alerts

ASH Publications

American Society of Hematology

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only